Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  45,176 results for ""Glyburide""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Glyburide use is associated with a greater likelihood of mortality or rehospitalization after acute coronary syndrome compared to gliclazide use in adults with type 2 diabetes: A cohort study.

  • Authors : Long W; Alberta Diabetes Institute, University of Alberta, 1-005 Li Ka Shing Centre for Health Research Innovation, Edmonton, Alberta, Canada.; Department of Pharmacology, Faculty of Medicine and Dentistry, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/mortality ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Nov; Vol. 26 (11), pp. 5408-5419. Date of Electronic Publication: 2024 Sep 09.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Identification and in vitro genotoxicity assessment of forced degradation products of glimepiride and glyburide using HEK cell-based COMET assay.

  • Authors : Jain R; Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER) Hajipur, Bihar, India.; Aishwarya D

Subjects: Sulfonylurea Compounds*/Sulfonylurea Compounds*/Sulfonylurea Compounds*/chemistry ; Sulfonylurea Compounds*/Sulfonylurea Compounds*/Sulfonylurea Compounds*/analysis ; Sulfonylurea Compounds*/Sulfonylurea Compounds*/Sulfonylurea Compounds*/toxicity

  • Source: Biomedical chromatography : BMC [Biomed Chromatogr] 2024 Dec; Vol. 38 (12), pp. e6025. Date of Electronic Publication: 2024 Oct 10.Publisher: Wiley Country of Publication: England NLM ID: 8610241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-0801

Record details

Read More Add to Saved list
×
Academic Journal

Glyburide Suppresses Inflammation-Related Colorectal Tumorigenesis Through Inhibition of NLRP3 Inflammasome.

  • Authors : Maeda T; Department of Gastroenterology, Graduate School of Medicine, Gifu University, Gifu 501-1194, Japan.; Shirakami Y

Subjects: NLR Family, Pyrin Domain-Containing 3 Protein*/NLR Family, Pyrin Domain-Containing 3 Protein*/NLR Family, Pyrin Domain-Containing 3 Protein*/metabolism ; NLR Family, Pyrin Domain-Containing 3 Protein*/NLR Family, Pyrin Domain-Containing 3 Protein*/NLR Family, Pyrin Domain-Containing 3 Protein*/genetics ; Glyburide*/Glyburide*/Glyburide*/pharmacology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Oct 30; Vol. 25 (21). Date of Electronic Publication: 2024 Oct 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read More Add to Saved list
×
Academic Journal

Glyburide confers neuroprotection against age-related macular degeneration (AMD).

  • Authors : Picard E; Inserm UMRS1138, Team 1: Physiopathology of ocular diseases-Therapeutic innovations, Centre de Recherche des Cordeliers, Paris, France; Sorbonne Université UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France

Subjects: Glyburide*/Glyburide*/Glyburide*/pharmacology ; Glyburide*/Glyburide*/Glyburide*/therapeutic use ; Macular Degeneration*/Macular Degeneration*/Macular Degeneration*/drug therapy

  • Source: Translational research : the journal of laboratory and clinical medicine [Transl Res] 2024 Oct; Vol. 272, pp. 81-94. Date of Electronic Publication: 2024 May 29.Publisher: Elsevier Country of Publication: United States NLM ID: 101280339 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Oral Glyburide for the Prevention of Cerebral Edema in Acute Ischemic Stroke.

  • Authors : Wilkinson B; Pharmacy Department, Cooper University Health Care, Camden, New Jersey, USA; Philadelphia College of Pharmacy, Saint Joseph's University, Philadelphia, Pennsylvania, USA. Electronic address: .

Subjects: Brain Edema*/Brain Edema*/Brain Edema*/prevention & control ; Brain Edema*/Brain Edema*/Brain Edema*/etiology ; Glyburide*/Glyburide*/Glyburide*/therapeutic use

  • Source: World neurosurgery [World Neurosurg] 2024 Jun; Vol. 186, pp. e608-e613. Date of Electronic Publication: 2024 Apr 07.Publisher: Elsevier Country of Publication: United States NLM ID: 101528275 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and Safety of Early Treatment with Glibenclamide in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized Controlled Trial.

  • Authors : Lin Q; Department of Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China.; Zhou D

Subjects: Subarachnoid Hemorrhage*/Subarachnoid Hemorrhage*/Subarachnoid Hemorrhage*/drug therapy ; Subarachnoid Hemorrhage*/Subarachnoid Hemorrhage*/Subarachnoid Hemorrhage*/complications ; Glyburide*/Glyburide*/Glyburide*/administration & dosage

  • Source: Neurocritical care [Neurocrit Care] 2024 Dec; Vol. 41 (3), pp. 828-839. Date of Electronic Publication: 2024 Aug 08.Publisher: Humana Press Country of Publication: United States NLM ID: 101156086 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

New Insights on the potential therapeutic effects of glibenclamide and Obeticholic acid against Alloxan-Induced diabetes mellitus in rat model.

  • Authors : Aboushouk AA; Department of Pathology and Clinical Pathology, Faculty of Veterinary Medicine, Alexandria University, Egypt. Electronic address: .; Saad HM

Subjects: Chenodeoxycholic Acid*/Chenodeoxycholic Acid*/Chenodeoxycholic Acid*/analogs & derivatives ; Chenodeoxycholic Acid*/Chenodeoxycholic Acid*/Chenodeoxycholic Acid*/therapeutic use ; Chenodeoxycholic Acid*/Chenodeoxycholic Acid*/Chenodeoxycholic Acid*/pharmacology

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 Dec 25; Vol. 143 (Pt 2), pp. 113469. Date of Electronic Publication: 2024 Oct 29.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.

Subjects: Glyburide*/Glyburide*/Glyburide*/administration & dosage ; Glyburide*/Glyburide*/Glyburide*/therapeutic use ; Brain Edema*/Brain Edema*/Brain Edema*/drug therapy

  • Source: The Lancet. Neurology [Lancet Neurol] 2024 Dec; Vol. 23 (12), pp. 1205-1213.Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print Cited Medium: Internet ISSN: 1474-4465

Record details

Read More Add to Saved list
×
Academic Journal

Vitamin D supplementation could enhance the effectiveness of glibenclamide in treating type 2 diabetes by improving the function of pancreatic β-cells through the NF-κB pathway.

  • Authors : Jia R; School of Nursing, Shanxi University of Chinese Medicine, No. 121, Daxue Street, Higher Education Park, Jinzhong City, Shanxi Province, 030619, China.; Liang L

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/pathology

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Nov 12; Vol. 733, pp. 150596. Date of Electronic Publication: 2024 Aug 27.Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage: a randomised, double-blind, placebo-controlled clinical trial.

  • Authors : Feng X; Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, China.; Zhang T

Subjects: Glyburide*/Glyburide*/Glyburide*/adverse effects ; Glyburide*/Glyburide*/Glyburide*/administration & dosage ; Glyburide*/Glyburide*/Glyburide*/therapeutic use

  • Source: Stroke and vascular neurology [Stroke Vasc Neurol] 2024 Nov 05; Vol. 9 (5), pp. 530-540. Date of Electronic Publication: 2024 Nov 05.Publisher: BMJ Country of Publication: England NLM ID: 101689996 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-8696

Record details

Read More Add to Saved list
×
  • 1-10 of  45,176 results for ""Glyburide""